The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5) February 1, 2021 No Comments Read More »
Tedious, Tiresome, and Dull: An Unrecognized Problem That We Can Solve January 25, 2021 No Comments Read More »
Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study January 20, 2021 No Comments Read More »
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI January 1, 2021 No Comments Read More »
The influence of time in range on daily mood in adults with type 1 diabetes December 15, 2020 No Comments Read More »
The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study December 1, 2020 No Comments Read More »
Impact of Participation in a Virtual Diabetes Clinic on Diabetes-Related Distress in Individuals With Type 2 Diabetes October 1, 2020 No Comments Read More »
Impact of Real-Time Continuous Glucose Monitoring Data Sharing on Quality of Life and Health Outcomes in Adults with Type 1 Diabetes September 29, 2020 No Comments Read More »
The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4) September 1, 2020 No Comments Read More »
Improvement in Patient-Reported Outcomes in Adults with Type 1 Diabetes Treated with Sotagliflozin plus Insulin Versus Insulin Alone July 28, 2020 No Comments Read More »
